Market Overview:
The global pap smear and HPV testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of cervical cancer, technological advancements in the field of pap smear and HPV testing, and rising demand for early diagnosis and treatment of cervical cancer. Based on type, the global pap smear and HPV testing market is segmented into monoclonal antibodies, polyclonal antibodies, immunoassays, molecular diagnostics, chromosomal analysis, and other analyses. Monoclonal antibodies are expected to account for the largest share of the global pap smear and HPV testing market in 2018. This segment is projected to grow at a CAGR of 8% from 2018 to 2030 due to its high specificity and sensitivity.
Product Definition:
A Pap smear is a test that helps screen for cervical cancer. It involves collecting cells from the cervix and examining them under a microscope. HPV testing is used to detect the presence of human papillomavirus (HPV), which can cause cervical cancer. Both tests are recommended for women age 21 and older, but HPV testing may also be done on younger women who have risk factors for cervical cancer.
Monoclonal and Polyclonal Antibodies:
Monoclonal and polyclonal antibodies are extensively used in Pap smear & HPV testing market. The growth factor for the market is increasing prevalence of cervical cancer which leads to increase in demand for diagnostic tests. According to CDC, every year around 12,000 women die due to cervical cancer making it the third most common cause of deaths among American women after heart disease and stroke.
Immunoassays:
Immunoassays are a group of techniques that involve the use of antibodies and their binding partners to study the structure and function of an antigen. The most common application is in allergy testing where it is used for detecting food additives, latex proteins, or other substances that cause allergies.
Application Insights:
Medical application of the tests accounted for the largest share in 2017 owing to increasing awareness about cancer and its early diagnosis. According to a study published by NCBI, it is estimated that around 52% of total cancer cases are diagnosed in advanced stages when treatment is easier and more effective. Thus, pap smear testing plays an important role in detecting cancer at initial stages as treatment with surgery & radiation therapy can be initiated right away.
The others segment includes gynecological applications such as cervical screening programs, human chorionic gonadotropin (hCG) testing for pregnancy detection, endometrial ablation procedures etc. Pap smears are used to screen women between ages 21 and 65 years for abnormal cells which may indicate the presence of cervical or other types of cancers. Thus, demand from medical field is expected to remain high whereas demand from other fields may witness a slow growth rate due to limited penetration & adoption rate among various organizations/government bodies etc.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high disposable income, and availability of advanced healthcare infrastructure. Moreover, rising incidence rate of cancer is also expected to boost demand for these tests in this region. According to statistics published by American Cancer Society in 2018, it was estimated that 1 out of 4 women would be diagnosed with invasive breast cancer over their lifetime and 1 out of 8 women would be diagnosed with invasive cervical cancer during their lifetime.
Asia Pacific is expected witness lucrative growth during the forecast period owing to growing target population base coupled with increase in prevalence rates for various cancers such as cervical & vaginal cancers and penile/perineal/Anal glandular tumors among others (ICD-10).
Growth Factors:
- Increasing incidence of cervical cancer: The incidence of cervical cancer is increasing at an alarming rate across the globe. This is primarily due to the rising number of HPV infections. According to a study by the World Health Organization (WHO), there were approximately 528,000 new cases of cervical cancer and 266,000 deaths due to this disease in 2012. The number of cases is expected to rise further in the coming years owing to population growth and aging. This will create a strong demand for Pap smear & HPV testing services, thereby driving market growth.
- Growing awareness about HPV and its association with cervical cancer: There is growing awareness among people about human papillomavirus (HPV) and its association with cervical cancer. This has led to an increase in demand for Pap smear & HPV testing services worldwide as more people are seeking preventive care measures against this deadly disease.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pap Smear & HPV Testing Market Research Report
By Type
Monoclonal and Polyclonal Antibodies, Immunoassays, Molecular Diagnostics, Chromosomal Analysis, Other Analyses
By Application
Medical Application, Others
By Companies
Abbott Laboratories, Ascon Medical Instruments, Becton, Beckman Coulter, Cardinal Health, Cooper Surgical, Johnson & Johnson, F. Hoffmann-La Roche, Guided Therapeutics, Olympus, Siemens Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
122
Number of Tables & Figures
86
Customization Available
Yes, the report can be customized as per your need.
Global Pap Smear & HPV Testing Market Report Segments:
The global Pap Smear & HPV Testing market is segmented on the basis of:
Types
Monoclonal and Polyclonal Antibodies, Immunoassays, Molecular Diagnostics, Chromosomal Analysis, Other Analyses
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical Application, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Ascon Medical Instruments
- Becton
- Beckman Coulter
- Cardinal Health
- Cooper Surgical
- Johnson & Johnson
- F. Hoffmann-La Roche
- Guided Therapeutics
- Olympus
- Siemens Healthcare
Highlights of The Pap Smear & HPV Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monoclonal and Polyclonal Antibodies
- Immunoassays
- Molecular Diagnostics
- Chromosomal Analysis
- Other Analyses
- By Application:
- Medical Application
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pap Smear & HPV Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pap Smear is a procedure that uses a microscope to look for abnormal cells on the surface of the cervix. HPV testing is used to determine if someone has been exposed to HPV, which can cause cervical cancer.
Some of the key players operating in the pap smear & hpv testing market are Abbott Laboratories, Ascon Medical Instruments, Becton, Beckman Coulter, Cardinal Health, Cooper Surgical, Johnson & Johnson, F. Hoffmann-La Roche, Guided Therapeutics, Olympus, Siemens Healthcare.
The pap smear & hpv testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pap Smear & HPV Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pap Smear & HPV Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pap Smear & HPV Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pap Smear & HPV Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pap Smear & HPV Testing Market Size & Forecast, 2020-2028
4.5.1 Pap Smear & HPV Testing Market Size and Y-o-Y Growth
4.5.2 Pap Smear & HPV Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Monoclonal and Polyclonal Antibodies
5.2.2 Immunoassays
5.2.3 Molecular Diagnostics
5.2.4 Chromosomal Analysis
5.2.5 Other Analyses
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Medical Application
6.2.2 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pap Smear & HPV Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pap Smear & HPV Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Monoclonal and Polyclonal Antibodies
9.6.2 Immunoassays
9.6.3 Molecular Diagnostics
9.6.4 Chromosomal Analysis
9.6.5 Other Analyses
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Medical Application
9.10.2 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Monoclonal and Polyclonal Antibodies
10.6.2 Immunoassays
10.6.3 Molecular Diagnostics
10.6.4 Chromosomal Analysis
10.6.5 Other Analyses
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Medical Application
10.10.2 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Monoclonal and Polyclonal Antibodies
11.6.2 Immunoassays
11.6.3 Molecular Diagnostics
11.6.4 Chromosomal Analysis
11.6.5 Other Analyses
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Medical Application
11.10.2 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Monoclonal and Polyclonal Antibodies
12.6.2 Immunoassays
12.6.3 Molecular Diagnostics
12.6.4 Chromosomal Analysis
12.6.5 Other Analyses
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Medical Application
12.10.2 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Monoclonal and Polyclonal Antibodies
13.6.2 Immunoassays
13.6.3 Molecular Diagnostics
13.6.4 Chromosomal Analysis
13.6.5 Other Analyses
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Medical Application
13.10.2 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pap Smear & HPV Testing Market: Competitive Dashboard
14.2 Global Pap Smear & HPV Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Ascon Medical Instruments
14.3.3 Becton
14.3.4 Beckman Coulter
14.3.5 Cardinal Health
14.3.6 Cooper Surgical
14.3.7 Johnson & Johnson
14.3.8 F. Hoffmann-La Roche
14.3.9 Guided Therapeutics
14.3.10 Olympus
14.3.11 Siemens Healthcare
